<DOC>
	<DOC>NCT01014078</DOC>
	<brief_summary>The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% in dry eye subjects over a four week treatment period, using placebo as a comparison.</brief_summary>
	<brief_title>A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Have a current diagnosis of dry eye in one or both eyes Moderate to severe degree of meibomian gland plugging Have best corrected visual acuity in both eyes of at least +0.7 LogMAR If female, are nonpregnant or nonlactating Have anterior blepharitis Have lid structural abnormalities Have suspected ocular fungal or viral infection Have had penetrating intraocular surgery in the past 90 days or require penetrating intraocular surgery during the study Have had ocular surface surgery [e.g., laserassisted in situ keratomileusis (LASIK), refractive, pterygium] within the past year. Unable to withhold the use of contact lenses during the study Have a known hypersensitivity to azithromycin, erythromycin, any other macrolide antibiotic, or any of the other ingredients in the study medication. Have a history of post vitreous detachment. Are considered legally blind in 1 eye (LogMAR BCVA= 1.0 or Snellen BCVA= 20/200). Have permanent conjunctival goblet cell loss or scarring conditions, including cicatricial blepharitis or conjunctivitis. Have a congenitally absent meibomian gland or lacrimal gland. Have had cauterization of the punctum or have had punctal plugs (silicone or collagen) inserted or removed within the 90 days prior to the screening. Have a serious medical condition which would confound study assessments. Have a concomitant ocular pathology that, in the opinion of the investigator, may confound study assessments.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>